Keyword: UC San Francisco
The past week brought new insights into how beige fat cells burn glucose, a particular protein foretells Alzheimer's and bacteria evade antibiotics.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
UC Berkeley scientists are using a new CRISPR delivery system to more safely correct the mutated dystrophin gene in mouse models of DMD.
The past week brought news of discoveries in neuroblastoma, type 1 diabetes and multiple sclerosis.
The financing gives Laura Deming, who started work on the fund before turning 18, $22 million to invest in companies working on age-related diseases.
Sean Parker’s immuno-oncology institute has allied with Tessa Therapeutics to turn T-cell therapies against solid tumors.
Fierce 15 winner C4 Therapeutics has become the latest biopharma to strike a deal with the Google-backed life sciences company Calico, although true to its quiet nature few details about the pact have emerged.
GE Healthcare and UC San Francisco have teamed up to build a library of deep learning algorithms that cut the time it takes to diagnose conditions.
Sickle cell disease is caused by a mutation in the gene that codes for the protein beta-globin, a component of red blood cells. A group of physicians and researchers have used CRISPR/Cas9 editing to correct the mutation in stem cells taken from the blood of affected patients.
UC San Francisco has landed $24 million in National Science Foundation funding to set up the Center for Cellular Construction.